55V-68647-97462
5 vaccinations
4 coded responses
47 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 327 / FL
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Pfizer-BioNTech
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-31
-
2021-02-06
Dose 2 — Pfizer-BioNTech
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-05-08
- 2021-08-07
-
2021-09-25
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain — Feeling: GoodFree text: Minor muscle pain at injection site starting about 6 hours after and lasting until next morning. Nothing further.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-07
- 2021-12-25
-
2022-03-26
Survey response — 6 months, dose 3MedDRA: COVID-19, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID positive Jan 11-21, 2022. Mild symptoms included sore throat, headache, minor respiratory congestion. Symptoms presented for approx 4 days followed by 3 additional days of fatigue. Negative test as of Jan 21, 2022. No long term symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-11
Dose 4 — Pfizer-BioNTech
- 2022-04-15
- 2022-04-16
- 2022-04-18
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
-
2022-07-11
Survey response — 3 months, dose 4MedDRA: COVID-19, Cough, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough, congestion, sore throat, headache, extreme fatigue Three negative home tests for COVID but suspect it was COVID anywayMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Dose 5 — Pfizer-BioNTech
-
2022-09-24
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2022-09-25
- 2022-09-26
- 2022-09-28
- 2022-10-02
- 2022-10-07
- 2022-10-15
- 2022-10-21
- 2022-10-30
- 2022-11-04
- 2022-12-24
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-11 | Pfizer-BioNTech | No |
| 5 | 2022-09-23 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Minor muscle pain at injection site starting about 6 hours after and lasting until next morning. Nothing further.
Release 11 — 6 months, dose 3
Symptoms: COVID positive Jan 11-21, 2022. Mild symptoms included sore throat, headache, minor respiratory congestion. Symptoms presented for approx 4 days followed by 3 additional days of fatigue. Negative test as of Jan 21, 2022. No long term symptoms.
Release 12 — 3 months, dose 4
Symptoms: Cough, congestion, sore throat, headache, extreme fatigue Three negative home tests for COVID but suspect it was COVID anyway
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): No
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release